Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 18 (2002), Issue 2, Pages 41-46
http://dx.doi.org/10.1155/2002/929274

Overview of Biomarkers and Surrogate Endpoints in Drug Development

John A. Wagner

Department of Clinical Pharmacology, Merck Research Laboratories, Rahway, NJ, USA

Received 18 September 2002; Accepted 18 September 2002

Copyright © 2002 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

John A. Wagner, “Overview of Biomarkers and Surrogate Endpoints in Drug Development,” Disease Markers, vol. 18, no. 2, pp. 41-46, 2002. doi:10.1155/2002/929274